Tony Cundell - Articles and news items

Microbiology pipette test tube

Microbiology: Mould contamination in pharmaceutical drug products and medical devices

Issue 6 2013, Microbiology / RMMs / 15 December 2013 / Tony Cundell, formerly of Merck Research Laboratories

Invasive fungal infections associated with high mortality rates are common in hospital settings, especially in intensive care units where patients may be immune-compromised, subject to invasive procedures and treated aggressively with antibiotics. The most common nosocomial fungal infections in descending order are due to the genera Candida, Aspergillus, Rhizopus, Fusarium and other less frequently isolated moulds. Usually the fungi are passed on from the hands of medical personnel, the indigenous microflora of the patient or the general hospital environment but occasionally pharmaceutical drug products and medical devices are implicated…

The current market and future trends for RMM

Issue 5 2006, Past issues / 28 September 2006 / Tony Cundell, Director, Pharmaceutical Sciences – Microbiology, Schering Plough Research Institute

Following on from our latest report in Issue 4 in which we outlined independent views on ‘solutions for the next stage’ in Rapid Microbiological Methods (RMM) from some of the industry’s leading names, Tony Cundell follows up with his own thoughts on this exciting field.


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...